Transcription Factors of CAT1, EFG1, and BCR1 Are Effective in Persister Cells of Candida albicans-Associated HIV-Positive and Chemotherapy Patients
Open accessAbstract
Background: Biofilm is an accumulation of cells, which are formed on mucosal surfaces of the host as well as on medical devices. The inherent resistance of Candida strains producing biofilms to antimicrobial agents is an important and key feature for biofilm growth, which can lead to treatment failure. This resistance is due to the regulatory increase of the output pumps, the presence of extracellular matrix, and the existence of persister cells. Persister cells are phenotypic variants that have MICs similar to antibiotic-sensitive populations and are able to tolerate high doses of antibiotics. The current study investigated the possible role of EFG1, BCR1, and CAT1 in the establishment or maintenance of persister cells in Candida albicans strains that produce biofilms. Methods: After identifying Candida isolates by molecular methods, C. albicans isolates were confirmed by sequencing. Isolation of persister cells and determination of their MIC were performed by microdilution method. Then, RNA extraction and cDNA synthesis were performed from 60 C. albicans isolates under promoting and inducing conditions. Afterward, the mean expression of BCR1, EFG1, and CAT1 genes in both persister and non-persister groups was calculated using real-time qPCR. Phylogeny tree of persister and non-persister group isolates was drawn using ITS fragment. Results: A total of 77 persister isolates were taken from the oral cavity of HIV patients as well as from patients undergoing chemotherapy. Biofilm intensity in persister isolates separated from HIV-infected patients was different from the non-persister group. The mean fold change of BCR1 (10.73), CAT1 (15.34), and EFG1 (2.41) genes in persister isolates was significantly higher than these genes in isolates without persister. Conclusion: It can be concluded that the most important factor in the production of persister cells is biofilm binding and production, not biofilm development or mature biofilm production, which was found in the expression of BCR1 gene without change in the expression of EFG1 gene in the persister group. Also, catalase plays an essential role in the production of persister in C. albicans biofilm producers with ROS detoxification.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BCR1 exhibits significantly higher expression in persistent C. albicans populations compared to non-persistent groups, both with and without AmB induction.
“Further, BCR1, a gene that promotes biofilm formation by regulating adhesion through the major surface adhesins Hwp1 and Als3, exhibits significantly higher expression in persistent C. albicans populations compared to non-persistent groups, both with and without AmB induction.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [81]
The Results (Inducing Condition, Table 5) report significantly higher BCR1 expression in persister isolates under inducing conditions (p = 0.008). Under promoting conditions, expression was higher but not significant (p = 0.08), so the claim of significance in both conditions is unsupported. The Methods define these conditions by biofilm formation, not by the presence or absence of AmB induction; page numbers are unavailable in our copy. (LLM, conf=0.92)
Experimental — accuracy not yet measuredEFG1 has no significant difference between the two groups.
“Meanwhile, EFG1, a gene regulates biofilm development and cell morphology, has no significant difference between the two groups [81].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690 · see citing works
<i>Candida albicans</i> Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521 · see citing works
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of <i>Candida albicans</i>
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237 · see citing works
Portrait of Candida albicans Adherence Regulators
Finkel, J. S., Xu, W., Huang, D., Hill, E. M., Desai, J. V., Woolford, C. A., Nett, J. E., Taff, H., Norice, C. T., Andes, D. R., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002525 · Cited by 228 · see citing works
Dwivedi, P., Thompson, A., Xie, Z., Kashleva, H., Ganguly, S., Mitchell, A. P., & Dongari-Bagtzoglou, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016218 · Cited by 110 · see citing works
Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95 · see citing works
Truong, T., Zeng, G., Qingsong, L., Kwang, L. T., Tong, C., Chan, F. Y., Wang, Y., & Seneviratne, C. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061523 · Cited by 45 · see citing works
Flagged first, then by citations
Research works printed but not linked: 41
- Aboualigalehdari E. Birgani M. T. Fatahinia M. Hosseinzadeh M. (2020). Oral colonization by Candida species and associated factors in HIV-infected patients in Ahvaz, southwest Iran. Epidemiol. Health 42: e2020033. 10.4178/epih.e2020033 32512666 PMC7644944 · DOI
- Aboualigalehdari E. Ghafourian S. Sadeghifard N. Sekawi Z. (2013). Is Candida albicans a cause of nosocomial infection in Iran? Rev. Med. Microbiol. 24 85– 88. 10.1097/mrm.0b013e3283642433 · DOI
- Abraham S. B. Al Marzooq F. Himratul-Aznita W. H. Ahmed H. M. A. Samaranayake L. P. (2020). Prevalence, virulence and antifungal activity of C. albicans isolated from infected root canals. BMC Oral Health 20: 347. 10.1186/s12903-020-01347-5 33256696 PMC7708210 · DOI
- Ahmad S. Khan Z. Asadzadeh M. Theyyathel A. Chandy R. (2012). Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infect. Dis. 12: 230. 10.1186/1471-2334-12-230 23009343 PMC3541108 · DOI
- Alonso G. C. Pavarina A. C. Sousa T. V. Klein M. I. (2018). A quest to find good primers for gene expression analysis of Candida albicans from clinical samples. J. Microbiol. Methods 147 1– 13. 10.1016/j.mimet.2018.02.010 29454005 · DOI
- Balaban N. Q. Merrin J. Chait R. Kowalik L. Leibler S. (2004). Bacterial persistence as a phenotypic switch. Science 305 1622– 1625. 10.1126/science.1099390 15308767 · DOI · Paper page
- Bink A. Vandenbosch D. Coenye T. Nelis H. Cammue B. P. Thevissen K. (2011). Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 55 4033– 4037. 10.1128/aac.00280-11 21746956 PMC3165342 · DOI · Paper page
- Cohen N. R. Lobritz M. A. Collins J. J. (2013). Microbial persistence and the road to drug resistance. Cell Host Microbe 13 632– 642. 10.1016/j.chom.2013.05.009 23768488 PMC3695397 · DOI
- Costa-de-Oliveira S. Rodrigues A. G. (2020). Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal. Microorganisms 8: 154. 10.3390/microorganisms8020154 31979032 PMC7074842 · DOI · Paper page
- De Brucker K. De Cremer K. Cammue B. P. Thevissen K. (2016). Protocol for determination of the persister subpopulation in Candida albicans biofilms. Methods Mol. Biol. 1333 67– 72. 10.1007/978-1-4939-2854-5_6 26468100 · DOI
- El-Baz A. M. Mosbah R. A. Goda R. M. Mansour B. Sultana T. Dahms T. E. (2021). Back to nature: combating candida albicans biofilm, phospholipase and hemolysin using plant essential oils. Antibiotics 10: 81. 10.3390/antibiotics10010081 33467766 PMC7830859 · DOI
- Erköse G. Erturan Z. (2007). Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count. Mycoses 50 485– 490. 10.1111/j.1439-0507.2007.01393.x 17944711 · DOI
- Galdiero E. de Alteriis E. De Natale A. D’Alterio A. Siciliano A. Guida M. (2020). Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625. Sci. Rep. 10: 5780. 10.1038/s41598-020-62746-w 32238858 PMC7113253 · DOI · Paper page
- Jayachandran A. L. Katragadda R. Thyagarajan R. Vajravelu L. Manikesi S. Kaliappan S. (2016). Oral Candidiasis among cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern. Can. J. Infect. Dis. Med. Microbiol. 2016: 8758461. 27403171 PMC4923570
- Komalapriya C. Kaloriti D. Tillmann A. T. Yin Z. Herrero-de-Dios C. Jacobsen M. D. (2015). Integrative model of oxidative stress adaptation in the fungal pathogen Candida albicans. PLoS One 10: e0137750. 10.1371/journal.pone.0137750 26368573 PMC4569071 · DOI
- Kussell E. Kishony R. Balaban N. Q. Leibler S. (2005). Bacterial persistence: a model of survival in changing environments. Genetics 169 1807– 1814. 15687275 PMC1449587
- Lassak T. Schneider E. Bussmann M. Kurtz D. Manak J. R. Srikantha T. (2011). Target specificity of the Candida albicans Efg1 regulator. Mol. Microbiol. 82 602– 618. 10.1111/j.1365-2958.2011.07837.x 21923768 · DOI · Paper page
- Levin B. R. Concepción-Acevedo J. Udekwu K. I. (2014). Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr. Opin. Microbiol. 21 18– 21. 10.1016/j.mib.2014.06.016 25090240 PMC4253300 · DOI
- Lewis K. (2005). Persister cells and the riddle of biofilm survival. Biochemistry 70 267– 274. 10.1007/s10541-005-0111-6 15807669 · DOI
- Li W.-S. Chen Y.-C. Kuo S.-F. Chen F.-J. Lee C.-H. (2018). The impact of biofilm formation on the persistence of candidemia. Front. Microbiol. 9: 1196. 10.3389/fmicb.2018.01196 29915571 PMC5994545 · DOI
- Maheronnaghsh M. Fatahinia M. Dehghan P. Teimoori A. (2020). Identification of Candida species and antifungal susceptibility in cancer patients with oral lesions in ahvaz, Southern West of Iran. Adv. Biomed. Res. 9: 50. 10.4103/abr.abr_214_19 33457333 PMC7792871 · DOI
- Merseguel K. B. Nishikaku A. S. Rodrigues A. M. Padovan A. C. Ferreira R. C. de Azevedo Melo A. S. (2015). Genetic diversity of medically important and emerging Candida species causing invasive infection. BMC Infect. Dis. 15: 57. 10.1186/s12879-015-0793-3 25887032 PMC4339437 · DOI
- Mirhendi H. Makimura K. Khoramizadeh M. Yamaguchi H. (2006). A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi 47 225– 229. 10.3314/jjmm.47.225 16940958 · DOI
- Moazeni M. Khoramizadeh M. R. Teimoori-Toolabi L. Noorbakhsh F. Rezaie S. (2014). The effect of EFG1 gene silencing on down-regulation of SAP5 gene, by use of RNAi technology. Acta Med. Iran. 52 9– 14. 24658980
- Mulcahy L. R. Burns J. L. Lory S. Lewis K. (2010). Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192 6191– 6199. 10.1128/jb.01651-09 20935098 PMC2981199 · DOI
- Nakagawa Y. (2008). Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol. Immunol. 52 16– 24. 10.1111/j.1348-0421.2008.00006.x 18352908 · DOI
- Nobile C. J. Mitchell A. P. (2005). Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15 1150– 1155. 10.1016/j.cub.2005.05.047 15964282 · DOI · Paper page
- Patil S. Majumdar B. Sarode S. C. Sarode G. S. Awan K. H. (2018). Oropharyngeal candidosis in HIV-infected patients—an update. Front. Microbiol. 9: 980. 10.3389/fmicb.2018.00980 29867882 PMC5962761 · DOI
- Patra P. Klumpp S. (2013). Population dynamics of bacterial persistence. PLoS One 8: e62814. 10.1371/journal.pone.0062814 23675428 PMC3652822 · DOI
- Piekarska K. Hardy G. Mol E. van den Burg J. Strijbis K. van Roermund C. (2008). The activity of the glyoxylate cycle in peroxisomes of Candida albicans depends on a functional β-oxidation pathway: evidence for reduced metabolite transport across the peroxisomal membrane. Microbiology 154 3061– 3072. 10.1099/mic.0.2008/020289-0 18832312 · DOI
- Pradhan A. Herrero-de-Dios C. Belmonte R. Budge S. Garcia A. L. Kolmogorova A. (2017). Elevated catalase expression in a fungal pathogen is a double-edged sword of iron. PLoS Pathog. 13: e1006405. 10.1371/journal.ppat.1006405 28542620 PMC5456399 · DOI
- Putranti A. Asmarawati T. Rachman B. Hadi U. (2018). Oral candidiasis as clinical manifestation of HIV/AIDS infection in Airlangga University hospital patients. IOP Conf. Ser. Earth Environ. Sci. 125: 012063. 10.1088/1755-1315/125/1/012063 · DOI
- Silva G. Bernardi T. L. Schaker P. D. C. Menegotto M. Valente P. (2012). Rapid yeast DNA extraction by boiling and freeze-thawing without using chemical reagents and DNA purification. Braz. Arch. Biol. Technol. 55 319– 327. 10.1590/s1516-89132012000200020 · DOI
- Stewart B. Rozen D. E. (2012). Genetic variation for antibiotic persistence in Escherichia coli. Evolution 66 933– 939. 10.1111/j.1558-5646.2011.01467.x 22380453 · DOI
- Sun J. Li Z. Chu H. Guo J. Jiang G. Qi Q. (2016). Candida albicans amphotericin B-tolerant persister formation is closely related to surface adhesion. Mycopathologia 181 41– 49. 10.1007/s11046-015-9894-1 26381156 · DOI · Paper page
- Taff H. T. Mitchell K. F. Edward J. A. Andes D. R. (2013). Mechanisms of Candida biofilm drug resistance. Future Microbiol. 8 1325– 1337. 24059922 PMC3859465
- Van den Bergh B. Fauvart M. Michiels J. (2017). Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol. Rev. 41 219– 251. 10.1093/femsre/fux001 28333307 · DOI
- Veening J.-W. Smits W. K. Kuipers O. P. (2008). Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol. 62 193– 210. 10.1146/annurev.micro.62.081307.163002 18537474 · DOI
- Wu X. Zhang S. Li H. Shen L. Dong C. Sun Y. (2020). Biofilm formation of Candida albicans facilitates fungal infiltration and persister cell formation in vaginal candidiasis. Front. Microbiol. 11: 1117. 10.3389/fmicb.2020.01117 32582081 PMC7289921 · DOI
- Wuyts J. Van Dijck P. Holtappels M. (2018). Fungal persister cells: the basis for recalcitrant infections? PLoS Pathog. 14: e1007301. 10.1371/journal.ppat.1007301 30335865 PMC6193731 · DOI · Paper page
- Yamada Y. Makimura K. Merhendi H. Ueda K. Nishiyama Y. Yamaguchi H. (2002). Comparison of different methods for extraction of mitochondrial DNA from human pathogenic yeasts. Jpn. J. infect. Dis. 55: 122. 12403909
Cited by
Sorted by citations
de Alteriis, E., Maione, A., Falanga, A., Bellavita, R., Galdiero, S., Albarano, L., Salvatore, M. M., Galdiero, E., & Guida, M. (2021) · Antibiotics · doi:10.3390/antibiotics11010026 · Cited by 54 · see citing works
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12 · see citing works
- Authors
- Aboualigalehdari, E., Tahmasebi Birgani, M., Fatahinia, M., & Hosseinzadeh, M.
- Affiliations
- Ahvaz Jundishapur University of Medical Sciences (IR)
- Corresponding author
- Fatahinia, Mahnaz
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-24
- Volume
- 12
- Pages
- 651221-651221
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC8425484
- OpenAlex
- W3196239099
- Cited by
- 11
- References
- 7
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ahvaz Jundishapur University of Medical Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, persister cells, biofilm, transcription factors, BCR1, EFG1, CAT1, catalase, gene expression, HIV, chemotherapy patients, oral candidiasis, biofilm-associated infections, antifungal resistance, reactive oxygen species scavenging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review